Results 1 to 10 of about 743,371 (240)

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer. [PDF]

Cancer Res, 2020
Slavish PJ, Chi L, Yun MK, Tsurkan L, Martinez NE, Jonchere B, Chai SC, Connelly M, Waddell MB, Das S, Neale G, Li Z, Shadrick WR, Olsen RR, Freeman KW, Low JA, Price JE, Young BM, Bharatham N, Boyd VA, Yang J, Lee RE, Morfouace M, Roussel MF, Chen T, Savic D, Guy RK, White SW, Shelat AA, Potter PM.   +29 more
europepmc   +1 more source

BET inhibitors enhance the anti-cancer effect of etoposide by suppressing the MRN-ATM axis in the DNA damage response. [PDF]

Genes Dis
Li Z, Xu W, Chen F, Zhang J, Zhu WG.
europepmc   +1 more source

Selective N‐Terminal BET Bromodomain Inhibitors by Targeting Non‐Conserved Residues and Structured Water Displacement**

Angewandte Chemie - International Edition, 2021
Daniel A Harki, Hideki Aihara, William Pomerantz   +2 more
exaly  

Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections

Proceedings of the National Academy of Sciences of the United States of America, 2022
Zhifeng Yu, Kevin Duong, John C Faver
exaly  

BET bromodomain inhibitors

Current Opinion in Chemical Biology, 2022
Stefan Knapp, Martin Peter Schwalm
exaly  

Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies

ACS Medicinal Chemistry Letters, 2020
Carsten Bolm, Jan-Hendrik Schöbel, Steffen Koschmieder   +2 more
exaly  

Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development

Journal of Medicinal Chemistry, 2022
Liang Ouyang, Ji Fa Zhang, Yuxi Wang
exaly